Form D · Other Health Care
LYNCH REGENERATIVE MEDICINE, LLC
Franklin, TN · CIK 0002008439
Offering snapshot reported Jul 15, 2026 · SEC filing
- Reported sold
- $15M Offering amount: $17.5M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2026 | Initial | $15,000,004 | No comparison | 21 | SEC filing |
| Feb 1, 2024 | Initial | $3,750,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-590859
Source: Form D, filed Jul 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrea Madison Dini | Executive |
| Earl Douglas | Director |
| Samuel Lynch | Director, Executive, Promoter |
| Allison Lynch | Director |
| Tod Reed | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
302 Innovation Drive Suite 500
Franklin, TN, 37067
Franklin, TN, 37067